2023-09-12
Pharmesol
www.pharmesol.comHeadquarters
NYC 🗽
Employee Count
4
Year Founded
2023
Amount raised
$220k
Business model
B2B SaaS, per patient per month
Early traction
Signed first SMB customer and contracting with a few others.
Investors
In the US alone, over 4 billion prescriptions are dispensed annually. 👩🏽⚕️
Yet, countless patients are left puzzled over medication instructions, missed dosages, and navigating potential side effects.
To find answers, many are left chasing callbacks from their busy doctors or even taking that trip back to the pharmacy. 🤦🏼
This week's company provides an AI platform that assists patients in managing and understanding their medications.
Pharmesol is an AI-driven software that enables healthcare providers to automate medication management.
Automate: Pharmesol’s software provides 24/7 automated SMS dialogues, ensuring continuous guidance about medications.
Management: Pharmesol clarifies directions, helps patients recognize side effects, and directs major concerns to medical experts.
Bulleted Version
📈 Market positioning: With a rising emphasis on minimizing medication errors, the medication management system market is set to continue growing rapidly.
Pharmesol is positioned to support the 75% of patients who struggle to manage and take their medications as directed.
⚙️ Pharmacy efficiency: Pharmesol boosts operational efficiency through 24/7 management, improved patient adherence, and customer loyalty, while alleviating overstretched pharmacy staffs.
🤝 Ecosystem advantage: Pharmesol optimizes operations and insights across patients, pharmacies, clinicians, insurers, and pharmaceutical companies, unlocking new revenue opportunities and ecosystem-wide savings.
🚫 Liability concerns: Any misinformation or drug misuse as a result of information shared by the platform could pose significant liability risks for pharmacies and their clinicians.
🕰️ Training the model: Thoroughly training the AI for the vast array of medications, conditions, and patient types may be both costly and time-intensive.
📚 Learning curve: As healthcare providers and patients adopt Pharmesol, there could be a learning phase — both for how to use the software and recognizing when hands-on intervention is necessary.
Illuminate.health: Backed by Plug and Play.
Converse Health: undisclosed.
Neurality Health: undisclosed.
Medisafe: Backed by Sanofi Ventures, Octopus Ventures, M Ventures, Pitango VC, Triventures, lool ventures, and others.
WhyPharmesol
By minimizing the need for clinician input, offering 24/7 patient support, and enhancing pharmacy operational efficiency, Pharmesol is writing a new script for the future of telemedicine.📝
*Nothing in this content constitutes investment or legal advice. Conduct independent diligence and consult professional advisers before making investment decisions.*
Explore
other features
Sacramento, CA
2026-04-21
Elven
Elven is building a lightweight, multi-use, and high-performance fireproof material to protect modern infrastructure and battery-powered systems.
Business model
B2B
Austin, TX
2026-03-31
Polygraf
Polygraf is a real-time control layer that sits between employees and AI tools, ensuring companies can use AI freely without losing control of their data.
Business model
Selling directly to enterprises & selling tools to businesses for integration within their own security products
NYC
2026-03-17
Licensed To Glow
Licensed To Glow is a subscription marketplace where consumers pay a flat fee to discover, book, and return to trusted beauty and aesthetics providers.
Business model
Subscription fees